Cell and Bioscience

Scope & Guideline

Fostering Innovation in Biochemistry and Genetics

Introduction

Immerse yourself in the scholarly insights of Cell and Bioscience with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN-
PublisherBMC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationCELL BIOSCI / Cell Biosci.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The journal 'Cell and Bioscience' aims to advance knowledge in the fields of cellular and bioscience research through the dissemination of high-quality research articles that span a wide range of topics. Its core focus includes understanding cellular mechanisms, interactions, and the underlying biological processes that affect health and disease.
  1. Cellular Mechanisms and Signaling Pathways:
    Research articles often explore intricate signaling pathways and cellular mechanisms, including the role of various proteins, RNA modifications, and metabolic processes in health and disease.
  2. Stem Cell Biology and Regenerative Medicine:
    The journal frequently publishes studies on stem cell biology, differentiation, and their therapeutic applications in regenerative medicine and tissue engineering.
  3. Cancer Biology and Therapeutics:
    A significant portion of the research focuses on cancer biology, examining tumor biology, metastasis, and exploring novel therapeutic strategies and biomarkers.
  4. Neuroscience and Neurodegenerative Diseases:
    The journal addresses various aspects of neuroscience, including neural development, neuroinflammation, and neurodegenerative diseases, contributing to a better understanding of brain-related disorders.
  5. Microbiology and Infectious Diseases:
    Research on host-pathogen interactions, immune responses, and the development of therapeutic interventions against infectious diseases is a prominent theme.
  6. Metabolism and Disease:
    Studies related to metabolic disorders, their cellular mechanisms, and potential therapeutic interventions are also key areas of focus.
The journal is currently witnessing the emergence of several trending themes that reflect the latest advancements in cellular and bioscience research. These themes indicate a shift towards interdisciplinary approaches and innovative methodologies.
  1. RNA Modifications and Epitranscriptomics:
    There is a growing emphasis on the role of RNA modifications, particularly m6A and other epitranscriptomic changes, in regulating gene expression and their implications in various diseases, including cancer and neurodegenerative disorders.
  2. Microbiome and Host Interactions:
    Research exploring the interplay between the microbiome and host health is on the rise, particularly its influence on metabolic diseases, immune responses, and cancer progression.
  3. Organoid Models for Disease Modeling:
    The use of organoid technology is increasingly prominent, providing innovative platforms for studying disease mechanisms and testing therapeutic interventions in a more physiologically relevant context.
  4. Immunotherapy and Cancer Immunology:
    Publications focusing on the mechanisms of immunotherapy, including the role of immune checkpoints and the tumor microenvironment, are trending as researchers seek to enhance treatment efficacy.
  5. Metabolic Reprogramming in Cancer:
    Emerging studies are increasingly focusing on the metabolic pathways in cancer cells, exploring how metabolic reprogramming contributes to tumorigenesis and resistance to therapies.
  6. Gene Editing Technologies and Applications:
    The application of CRISPR/Cas9 and other gene editing technologies is gaining traction, with research exploring their potential in therapeutic contexts and the ethical implications surrounding their use.

Declining or Waning

While 'Cell and Bioscience' continues to evolve, certain themes appear to be declining in frequency or prominence. This may reflect shifts in research priorities or advancements in related fields.
  1. Basic Mechanisms of Epithelial-Mesenchymal Transition (EMT):
    Although EMT has been a significant area of study in cancer biology, the frequency of publications focusing solely on the mechanistic aspects of EMT appears to be decreasing, possibly due to a shift towards more integrative approaches that encompass broader cellular interactions.
  2. Traditional Pharmacological Approaches:
    There is a noticeable reduction in studies highlighting traditional pharmacological interventions, as the journal's focus is increasingly leaning towards innovative therapies, including gene editing and personalized medicine.
  3. In Vitro Models of Disease:
    The use of conventional in vitro models is becoming less prominent, as researchers are moving towards more complex and physiologically relevant models such as organoids and 3D cultures.
  4. Single-Cell Analysis Techniques:
    While single-cell technologies have gained significant attention, the specific focus on traditional single-cell sequencing methods is waning, with a greater emphasis now on integrating these techniques with spatial transcriptomics.

Similar Journals

LIFE SCIENCES

Connecting researchers to groundbreaking discoveries in life sciences.
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0024-3205Frequency: 24 issues/year

LIFE SCIENCES, published by PERGAMON-ELSEVIER SCIENCE LTD, is an esteemed international journal that has been advancing the field since its inception in 1962. With an ISSN of 0024-3205 and an E-ISSN of 1879-0631, it serves as a critical forum for researchers, professionals, and students within the realms of biochemistry, genetics, molecular biology, medicine, and pharmacology. Currently ranked in the Q1 category across multiple disciplines, including a remarkable 2nd rank in General Pharmacology, Toxicology, and Pharmaceutics, the journal maintains a prestigious position in academic circles, evidenced by its high impact factor and significant percentile ranks. While LIFE SCIENCES is not an open-access journal, it remains dedicated to publishing high-quality, peer-reviewed research that pushes the boundaries of knowledge and fosters innovation. With converged research interests leading into 2024, LIFE SCIENCES continues to be a pivotal resource for the dissemination of influential findings, making it an indispensable tool for those engaged in the life sciences.

MOLECULAR AND CELLULAR BIOCHEMISTRY

Pioneering Insights in Biochemistry and Medicine
Publisher: SPRINGERISSN: 0300-8177Frequency: 12 issues/year

MOLECULAR AND CELLULAR BIOCHEMISTRY, an esteemed journal published by SPRINGER, serves as a prominent platform in the fields of biochemistry and molecular biology. With a history of dissemination since 1973, this journal has made significant contributions to the understanding of biochemical processes at the molecular level. The MOLECULAR AND CELLULAR BIOCHEMISTRY journal focuses on a myriad of topics including but not limited to cellular biochemistry, clinical biochemistry, and interdisciplinary approaches in medicine, boasting a commendable categorization in the 2023 Scopus ranks where it falls under Q3 in Cell Biology, Q2 in Clinical Biochemistry, Q1 in Medicine (miscellaneous), and Q2 in Molecular Biology. Although the journal is not open access, it provides access options through institutional subscriptions, making valuable research accessible to a wider audience. With its rigorous peer-review process and high impact within the scientific community, this journal aims to advance knowledge and stimulate exploration in biochemical research, making it essential reading for researchers, professionals, and students alike.

Protein & Cell

Pioneering Discoveries in Protein Functions and Cellular Processes
Publisher: OXFORD UNIV PRESSISSN: 1674-800XFrequency: 12 issues/year

Protein & Cell, published by Oxford University Press, is a distinguished international journal focusing on cutting-edge research in the fields of biochemistry, biotechnology, cell biology, and drug discovery. This open access journal, active since 2014, is dedicated to disseminating innovative findings that advance our understanding of protein functions and cellular processes, making it an essential resource for researchers, professionals, and students alike. With an impressive 2023 impact factor reflected in its Q1 ranking across multiple categories such as Biochemistry, Drug Discovery, and Cell Biology, 'Protein & Cell' stands at the forefront of scientific research, driving collaboration and discussion in the scientific community. Researchers can access the journal freely online, fostering a global exchange of knowledge and contributing to significant advancements in medicine and biotechnology. Located in the United Kingdom, the journal strives to be a pivotal platform for impactful research that influences future studies and applications.

MOLECULAR MEDICINE

Connecting Science and Healthcare for a Better Future
Publisher: SPRINGERISSN: 1076-1551Frequency: 1 issue/year

MOLECULAR MEDICINE, published by SPRINGER, is a leading scholarly journal dedicated to advancing the fields of genetics and molecular biology with a focus on clinical applications. Since its inception in 1994, it has evolved to become a pivotal platform for disseminating innovative research findings, achieving a remarkable Q1 ranking in multiple categories, including Genetics, Molecular Biology, and Molecular Medicine as of 2023. Featuring an Open Access model since 2000, the journal ensures that cutting-edge research is freely available to the global scientific community, facilitating collaboration and knowledge exchange. With a commitment to high-quality peer-reviewed content, MOLECULAR MEDICINE serves as an essential resource for researchers, healthcare professionals, and students seeking to stay at the forefront of molecular research and its implications for medical science. For those interested in contributing to or accessing vital research in this dynamic field, MOLECULAR MEDICINE stands out as a premier choice.

CELL

Illuminating the pathways of cellular mechanisms.
Publisher: CELL PRESSISSN: 0092-8674Frequency: 26 issues/year

CELL is a premier academic journal in the field of Biochemistry, Genetics, and Molecular Biology, published by CELL PRESS. Founded in 1974, this esteemed journal has steadfastly contributed to advancing our understanding of cellular processes and organisms, making it integral for researchers and practitioners alike. With an impressive impact factor that places it in the Q1 category of its field, CELL ranks #1 out of 221 in general biochemistry and genetics, achieving a remarkable 99th percentile in Scopus rankings. Though it is not currently an open-access publication, the journal regularly disseminates high-quality research that impacts the scientific community significantly. Researchers, students, and professionals seeking to stay at the forefront of innovative discoveries and methodologies in molecular biology will find CELL an invaluable resource through its comprehensive articles and reviews.

JOURNAL OF CELLULAR PHYSIOLOGY

Elevating Understanding of Cellular Mechanisms
Publisher: WILEYISSN: 0021-9541Frequency: 12 issues/year

JOURNAL OF CELLULAR PHYSIOLOGY, published by Wiley, is a leading peer-reviewed journal that has been at the forefront of cellular research since its inception in 1945. With its prestigious Q1 and Q2 rankings in the fields of Clinical Biochemistry and Cell Biology, this journal is highly regarded within the scientific community, reflecting its significant impact factor and rigorous peer-review process. Addressing the intricacies of cell function and physiology, it serves as a crucial resource for researchers, professionals, and students dedicated to advancing knowledge in the life sciences. The journal publishes cutting-edge research articles, integral reviews, and significant findings that bridge basic biology and clinical applications, ensuring access to high-quality scholarly content that informs current practices and future research directions. Although not open access, the journal maintains a rich archive of studies, making it an essential reference point for those invested in the health and biological sciences.

BIOCELL

Fostering Excellence in Cell Research
Publisher: TECH SCIENCE PRESSISSN: 0327-9545Frequency: 12 issues/year

BIOCELL is a distinguished peer-reviewed journal dedicated to the field of Cell Biology, published by TECH SCIENCE PRESS. Since its inception in 1995, the journal has been at the forefront of disseminating innovative research, with converged publication years extending from 1995 to 2013 and from 2015 to 2024. Although it currently holds a Q4 ranking in the Cell Biology category according to the 2023 category quartiles, BIOCELL aims to foster advancements by providing a platform for researchers, professionals, and students to share their findings in biochemistry, genetics, and molecular biology. The journal is available in both print (ISSN: 0327-9545) and digital formats (E-ISSN: 1667-5746) and seeks to attract contributions that enhance scholarly dialogue and understandings of cellular mechanisms and innovations. With a commitment to quality research and critical discourse, BIOCELL plays an important role in nurturing the scientific community within Argentina and beyond, offering vital insights that contribute to the advancement of the life sciences.

Genes & Diseases

Connecting genetics to disease for transformative insights.
Publisher: KEAI PUBLISHING LTDISSN: 2352-4820Frequency: 6 issues/year

Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.

CELL RESEARCH

Pioneering Research for a Healthier Tomorrow
Publisher: SPRINGERNATUREISSN: 1001-0602Frequency: 12 issues/year

CELL RESEARCH is a premier peer-reviewed journal dedicated to advancing the field of cell biology and molecular biology, published by SpringerNature. With an impressive impact factor and consistently ranking in the Q1 quartile for both cell biology and molecular biology, this journal serves as a pivotal resource for researchers, professionals, and students seeking to explore the latest discoveries and advancements in cellular mechanisms and their implications for health and disease. Since its inception in 1996, CELL RESEARCH has cultivated a distinguished reputation, currently boasting ranks in the top percentile of Scopus categories, reaffirming its influence and relevance to the scientific community. Although it is not an Open Access journal, its rigorous selection process ensures the publication of high-quality articles that contribute significantly to our understanding of life sciences. For those deeply engaged in the realms of biochemistry, genetics, and molecular biology, CELL RESEARCH is an essential conduit of innovative research and critical insights.

JOURNAL OF CELL BIOLOGY

Pioneering Research in the Heart of Cell Biology
Publisher: ROCKEFELLER UNIV PRESSISSN: 0021-9525Frequency: 12 issues/year

JOURNAL OF CELL BIOLOGY, published by Rockefeller University Press, stands as a leading authority in the fields of Cell Biology and Medicine, reflected by its esteemed Q1 ranking in both categories as of 2023. Established in 1955, this journal has become a pivotal platform for disseminating groundbreaking research that enhances our understanding of cellular processes and their implications in various biological contexts. With a broad scope that encompasses experimental and theoretical studies alike, the JOURNAL OF CELL BIOLOGY embraces a rich diversity of topics, making it essential reading for researchers, students, and professionals committed to advancing cellular research. Although the journal does not currently offer open access options, its robust reputation, underscored by a competitive Scopus ranking of 43 out of 285 in the Cell Biology category, ensures that published findings reach a wide audience and influence the ongoing discourse in the life sciences. For those interested in staying at the forefront of cell biological research, the JOURNAL OF CELL BIOLOGY represents a critical resource.